Market Cap 65.86M
Revenue (ttm) 11.27M
Net Income (ttm) -10.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.71%
Debt to Equity Ratio 0.00
Volume 73,500
Avg Vol 239,794
Day's Range N/A - N/A
Shares Out 46.71M
Stochastic %K 64%
Beta 0.84
Analysts Sell
Price Target $4.33

Company Profile

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed it...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 620 4187
Address:
Industrious 823 Congress Ave, Suite 300, Austin, United States
Crewm8te
Crewm8te Aug. 24 at 1:58 PM
0 · Reply
InvitationW
InvitationW Aug. 24 at 1:58 AM
0 · Reply
EmielTheBlessed
EmielTheBlessed Aug. 23 at 1:57 PM
0 · Reply
VicFri
VicFri Aug. 23 at 1:57 AM
0 · Reply
LondonLeaves9845
LondonLeaves9845 Aug. 22 at 1:57 PM
0 · Reply
StockingGecks
StockingGecks Aug. 22 at 1:57 AM
0 · Reply
BellaChaw
BellaChaw Aug. 21 at 5:51 PM
$HYFT give me 2$
0 · Reply
KevinGuzman
KevinGuzman Aug. 21 at 1:57 PM
0 · Reply
DrunkLove
DrunkLove Aug. 21 at 1:57 AM
0 · Reply
Scam_Likely
Scam_Likely Aug. 20 at 8:00 PM
$HYFT to the mooooooon. Dumbass.
1 · Reply
Latest News on HYFT
MindWalk Holdings Registration statement: Registration filing

Jul 28, 2026, 8:00 AM EDT - 27 days ago

MindWalk Holdings Registration statement: Registration filing


MindWalk showcases ReefIQ for AI drug discovery

2026-07-23T20:26:44.000Z - 4 weeks ago

MindWalk showcases ReefIQ for AI drug discovery


MindWalk Holdings Earnings Call Transcript: Q4 2026

Jul 22, 2026, 5:00 PM EDT - 4 weeks ago

MindWalk Holdings Earnings Call Transcript: Q4 2026


MindWalk Holdings Earnings release: Q4 2026

Jul 22, 2026, 5:00 PM EDT - 4 weeks ago

MindWalk Holdings Earnings release: Q4 2026


MindWalk Holdings Annual report: Q4 2026

Jul 22, 2026, 5:00 PM EDT - 4 weeks ago

MindWalk Holdings Annual report: Q4 2026


MindWalk Holdings Slides: Q4 2026

Jul 22, 2026, 5:00 PM EDT - 4 weeks ago

MindWalk Holdings Slides: Q4 2026


MindWalk files $250M mixed securities shelf

2026-07-13T20:10:59.000Z - 5 weeks ago

MindWalk files $250M mixed securities shelf


MindWalk Holdings Registration statement: Registration filing

Jul 13, 2026, 8:00 AM EDT - 6 weeks ago

MindWalk Holdings Registration statement: Registration filing


MindWalk added to Russell 3000E Index

2026-07-06T12:41:35.000Z - 7 weeks ago

MindWalk added to Russell 3000E Index


MindWalk launches ReefIQ context layer

2026-06-10T13:25:28.000Z - 2 months ago

MindWalk launches ReefIQ context layer


MindWalk announces launch of Pandemic Response Platform

2026-05-27T14:28:47.000Z - 3 months ago

MindWalk announces launch of Pandemic Response Platform


The Biology Came First.

May 18, 2026, 8:34 AM EDT - 3 months ago

The Biology Came First.


MindWalk initiated with a Buy at JonesResearch

2026-04-15T20:18:56.000Z - 4 months ago

MindWalk initiated with a Buy at JonesResearch


MindWalk Holdings Earnings Call Transcript: Q3 2026

Mar 12, 2026, 10:30 AM EDT - 5 months ago

MindWalk Holdings Earnings Call Transcript: Q3 2026


MindWalk Holdings Earnings release: Q3 2026

Mar 12, 2026, 10:30 AM EDT - 5 months ago

MindWalk Holdings Earnings release: Q3 2026


MindWalk Holdings Slides: Q3 2026

Mar 12, 2026, 10:30 AM EDT - 5 months ago

MindWalk Holdings Slides: Q3 2026


MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results

Mar 12, 2026, 8:31 AM EDT - 5 months ago

MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results


MindWalk announces nanobody discovery platform

2026-03-06T21:05:43.000Z - 6 months ago

MindWalk announces nanobody discovery platform


MindWalk announces advance in influenza program

2026-01-11T19:45:16.000Z - 8 months ago

MindWalk announces advance in influenza program


MindWalk Holdings Earnings Call Transcript: Q2 2026

Dec 15, 2025, 10:30 AM EST - 8 months ago

MindWalk Holdings Earnings Call Transcript: Q2 2026


MindWalk Holdings Earnings release: Q2 2026

Dec 15, 2025, 10:30 AM EST - 8 months ago

MindWalk Holdings Earnings release: Q2 2026


MindWalk Holdings Slides: Q2 2026

Dec 15, 2025, 10:30 AM EST - 8 months ago

MindWalk Holdings Slides: Q2 2026


MindWalk appoints R. Scott Areglado as Chief Financial Officer

2025-10-21T13:10:11.000Z - 10 months ago

MindWalk appoints R. Scott Areglado as Chief Financial Officer


MindWalk appoints Thomas Lynch as chief business officer

2025-10-15T11:05:12.000Z - 11 months ago

MindWalk appoints Thomas Lynch as chief business officer


MindWalk announces up to 2.3M share stock repurchase program

2025-10-09T11:05:22.000Z - 11 months ago

MindWalk announces up to 2.3M share stock repurchase program


MindWalk Announces Share Repurchase Program

Oct 9, 2025, 7:00 AM EDT - 11 months ago

MindWalk Announces Share Repurchase Program


MindWalk advances AI-designed GLP-1 therapeutics program

2025-09-22T11:25:07.000Z - 1 year ago

MindWalk advances AI-designed GLP-1 therapeutics program


MindWalk Holdings Earnings Call Transcript: Q1 2026

Sep 15, 2025, 10:30 AM EDT - 1 year ago

MindWalk Holdings Earnings Call Transcript: Q1 2026


MindWalk Holdings Earnings release: Q1 2026

Sep 15, 2025, 10:30 AM EDT - 1 year ago

MindWalk Holdings Earnings release: Q1 2026


MindWalk Holdings Earnings Call Transcript: Q4 2025

Jul 29, 2025, 10:30 AM EDT - 1 year ago

MindWalk Holdings Earnings Call Transcript: Q4 2025


MindWalk Holdings Earnings release: Q4 2025

Jul 29, 2025, 10:30 AM EDT - 1 year ago

MindWalk Holdings Earnings release: Q4 2025


MindWalk Holdings Annual report: Q4 2025

Jul 29, 2025, 10:30 AM EDT - 1 year ago

MindWalk Holdings Annual report: Q4 2025


MindWalk Holdings Earnings Call Transcript: Q3 2025

Mar 28, 2025, 10:30 AM EDT - 1 year ago

MindWalk Holdings Earnings Call Transcript: Q3 2025


MindWalk Holdings Earnings release: Q3 2025

Mar 28, 2025, 10:30 AM EDT - 1 year ago

MindWalk Holdings Earnings release: Q3 2025


ImmunoPrecise Antibodies Announces Key Leadership Changes

Feb 24, 2025, 8:01 AM EST - 1 year ago

ImmunoPrecise Antibodies Announces Key Leadership Changes


Crewm8te
Crewm8te Aug. 24 at 1:58 PM
0 · Reply
InvitationW
InvitationW Aug. 24 at 1:58 AM
0 · Reply
EmielTheBlessed
EmielTheBlessed Aug. 23 at 1:57 PM
0 · Reply
VicFri
VicFri Aug. 23 at 1:57 AM
0 · Reply
LondonLeaves9845
LondonLeaves9845 Aug. 22 at 1:57 PM
0 · Reply
StockingGecks
StockingGecks Aug. 22 at 1:57 AM
0 · Reply
BellaChaw
BellaChaw Aug. 21 at 5:51 PM
$HYFT give me 2$
0 · Reply
KevinGuzman
KevinGuzman Aug. 21 at 1:57 PM
0 · Reply
DrunkLove
DrunkLove Aug. 21 at 1:57 AM
0 · Reply
Scam_Likely
Scam_Likely Aug. 20 at 8:00 PM
$HYFT to the mooooooon. Dumbass.
1 · Reply
ComeOnGuys
ComeOnGuys Aug. 20 at 7:55 PM
$HYFT 2nd lowest day of trading volume in FY 2026 so far lol
1 · Reply
Loweryy
Loweryy Aug. 20 at 1:57 PM
0 · Reply
Crabtrees
Crabtrees Aug. 20 at 1:57 AM
0 · Reply
windswept
windswept Aug. 19 at 7:08 PM
0 · Reply
NyseDayTrader
NyseDayTrader Aug. 19 at 6:26 PM
1 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Aug. 19 at 5:33 PM
$HYFT I’d say $TWST is going to eat our lunch, but we never had a lunch.
0 · Reply
Crabtrees
Crabtrees Aug. 19 at 1:57 PM
0 · Reply
KevinGuzman
KevinGuzman Aug. 19 at 1:57 AM
0 · Reply
NyseDayTrader
NyseDayTrader Aug. 19 at 12:30 AM
$HYFT 𝐓𝐨𝐩 𝐌𝐚𝐜𝐡𝐢𝐧𝐞 𝐋𝐞𝐚𝐫𝐧𝐢𝐧𝐠 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐄𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐜𝐡 𝐌𝐚𝐣𝐨𝐫 𝐆𝐫𝐨𝐰𝐭𝐡 𝐛𝐲 𝟐𝟎𝟑𝟒 🚀𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲: https://lnkd.in/gWRT7XJt 📊 The Machine Learning in Pharmaceutical Market is estimated at approximately US$5.5 billion in 2026 and is projected to approach US$18.7 billion by 2030, reflecting a CAGR of about 35.7%. Growth is being shaped by AI-enabled drug discovery, precision medicine, real-world data analytics, cloud platforms, and clinical-trial optimization. 🚀 Recent industry activity reinforces the investment momentum: Boehringer Ingelheim announced a £150 million, 10-year commitment around AI and ML capabilities, while Eli Lilly expanded its Insilico Medicine collaboration to a potential US$2.75 billion deal. ✅ Key Growth Drivers: • AI-enabled drug discovery and predictive analytics • Rising pharmaceutical R&D investment • Precision and personalized medicine • Increasing real-world data availability • Cloud-based ML platforms and automation 📦 Closed Systems Dominance: Not a validated market-wide finding; cloud and hybrid deployment are increasingly important deployment models. 📈 Fastest-Growing Region: Asia-Pacific ⚠️ Primary Restraint: Data silos, interoperability, privacy, validation, and regulatory complexity. 💡 Key Emerging Trends: Generative AI for de novo drug design, federated learning, digital biomarkers, wearable-data integration, automated clinical-trial optimization, and AI-assisted regulatory workflows. 🌍 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 North America remains the largest regional market, supported by strong pharmaceutical R&D intensity, advanced digital infrastructure, major technology providers, and established AI-pharma collaborations. 🏢 𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 ➢ Merit Solutions ➢ d-wise ➢ Hanker Analytics ➢ Savi Technology ➢ Reveal Biosciences ➢ InSilicoMinds ➢ Verix ➢ Infinant Health ➢ Ascend Tech Systems LLC ➢ Modicus Prime ➢ NextShift ➢ Beaconcure ➢ InflexionPoint ➢ Pangaea Data ➢ Nextnet ➢ Celeris Therapeutics ➢ Stark Pharma Solutions Inc ➢ eStaff Search Group ➢ Enthought, Inc. ➢ Lantern Pharma Inc. (Nasdaq: LTRN) ➢ Swoop ➢ Samay Consulting ➢ MindWalk Holdings Corp. <-------------------------- ➢ HeyDonto AI ➢ physIQ ➢ Medcase ➢ DHL Supply Chain ➢ Vertical Trail ➢ HiFiBiO Therapeutics ➢ MyHealthTeam ➢ Nabla Bio ➢ Simulations Plus, Inc. ➢ Intelligencia AI ➢ DataInsight ➢ ArtiXio ➢ Genesis Research Group ➢ Quantori ➢ Paige
0 · Reply
iambaron
iambaron Aug. 18 at 2:01 PM
$HYFT is there such thing as news here?
2 · Reply
Nolder
Nolder Aug. 18 at 1:57 PM
0 · Reply
RussMe
RussMe Aug. 18 at 1:57 AM
1 · Reply